Cargando…
Acetyltransferase p300 inhibitor reverses hypertension‐induced cardiac fibrosis
Epigenetic dysregulation plays a crucial role in cardiovascular diseases. Previously, we reported that acetyltransferase p300 (ATp300) inhibitor L002 prevents hypertension‐induced cardiac hypertrophy and fibrosis in a murine model. In this short communication, we show that treatment of hypertensive...
Autores principales: | Rai, Rahul, Sun, Tianjiao, Ramirez, Veronica, Lux, Elizabeth, Eren, Mesut, Vaughan, Douglas E., Ghosh, Asish K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433695/ https://www.ncbi.nlm.nih.gov/pubmed/30710427 http://dx.doi.org/10.1111/jcmm.14162 |
Ejemplares similares
-
A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis
por: Rai, Rahul, et al.
Publicado: (2017) -
Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease
por: Ghosh, Asish K.
Publicado: (2021) -
OR22-6 Reversal Of Diet Induced Metabolic Syndrome In Mice With An Orally Active Small Molecule Inhibitor Of PAI-1
por: Levine, Joshua, et al.
Publicado: (2019) -
p300 in Cardiac Development and Accelerated Cardiac Aging
por: Ghosh, Asish K
Publicado: (2020) -
A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence
por: Ghosh, Asish K., et al.
Publicado: (2016)